Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PM_183865)
Gottfried und Julia Bangerter-Rhyner-Stiftung (NA)
Received: 19 August 2020
Accepted: 4 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: All studies were approved by the national ethics committees.
: Not applicable.
: The authors have disclosed that they do not have conflict of interest. JFT received fees for lectures to 3M, MSD, Pfizer, and Biomerieux. JFT received research grants from Astellas, 3M, MSD, and Pfizer. JFT participated to advisory boards of 3M, MSD, Bayer Pharma, Nabriva, and Pfizer. BV reports grants, personal fees for lectures, and travel accommodations from Qiagen. BV received personal fees for lecture and travel accommodation support from BioMérieux. BV received personal fees for lectures from Hologic and Gilead.